Related Experiment Video

Updated: Aug 28, 2025

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

18.5K

An update regarding the role of WNK kinases in cancer

Mengxi Xiu1, Li Li1, Yandong Li2

  • 1Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China.

Cell Death & Disease
|September 19, 2022
PubMed

Insights

Mammalian WNK kinases (WNKs) are crucial for ion balance and blood pressure. Dysregulated WNK signaling contributes to cancer progression, offering potential therapeutic targets by inhibiting WNK-SPAK/OSR1 pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Mammalian WNK kinases (WNKs) are serine/threonine kinases regulating ion homeostasis and blood pressure.
  • Aberrant WNK signaling is implicated in tumor growth, metastasis, and angiogenesis.
  • WNKs primarily exert their functions by phosphorylating SPAK (SPS1-related proline/alanine-rich kinase) and OSR1 (oxidative stress-responsive kinase 1).

Purpose of the Study:

  • To review and discuss the multifaceted roles of WNKs in various cancer-related biological processes.
  • To explore the intricate relationships between WNKs and key factors involved in tumorigenesis.
  • To summarize potential therapeutic strategies targeting WNK-SPAK/OSR1 signaling in cancer.

Main Methods:

  • Literature review and synthesis of existing research on WNK kinases in cancer.
  • Analysis of WNKs' involvement in ion transport, signaling pathways, and cellular processes like angiogenesis and autophagy.
  • Discussion of emerging therapeutic approaches targeting WNK signaling pathways.

Main Results:

  • WNK dysregulation is linked to tumor growth, metastasis, and angiogenesis.
  • WNKs interact with ion channels, cotransporters (NCC, KCC, NBCs), signaling cascades, and non-coding RNAs in cancer.
  • Targeting WNK-SPAK/OSR1 signaling presents a promising avenue for cancer therapy.

Conclusions:

  • WNK kinases play a significant role in cancer development and progression.
  • Understanding WNK-mediated signaling provides insights into novel cancer vulnerabilities.
  • Further research into WNK inhibitors could lead to effective anti-cancer treatments.

More Related Videos

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.5K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.3K

Related Concept Videos

Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K